Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Archives of Physical Medicine and Rehabilitation|July 1, 1981
Standing balance in healthy boys and in children with Duchenne muscular dystrophyC R Kelly, J B Redford, S Zilber, et al.The Biochemical Journal|April 1, 1996
Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIaC R Kelly, J R Schullek, W Ruf, et al.British Journal of Cancer|February 5, 2004
Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancerM Yao, E C Lam, C R Kelly, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 22, 2004
Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cellsN A Sharif, C R Kelly, J Y Crider, et al.The Journal of Biological Chemistry|January 15, 2001
Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2P W Bergum, A Cruikshank, S L Maki, et al.Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1987
Progressive systemic sclerosis associated with exposure to trichloroethyleneJ E Lockey, C R Kelly, G W Cannon, et al.The Heart Surgery Forum|October 24, 2001
The advantages of the Harmonic Scalpel for the harvesting of radial arteries for coronary artery bypassC B Wright, H B Barner, A Gao, et al.Biochemistry|May 16, 1995
Energetic contributions and topographical organization of ligand binding residues of tissue factorW Ruf, C R Kelly, J R Schullek, et al.Journal of Medicinal Chemistry|April 2, 1993
Position 2 and position 2/Ala15-substituted analogs of bovine growth hormone-releasing factor (bGRF) with enhanced metabolic stability and improved in vivo bioactivityT M Kubiak, A R Friedman, R A Martin, et al.Pageof 2